Cargando…

Towards Personalization in the Curative Treatment of Gastric Cancer

Gastric cancer is the fifth most common cancer worldwide and has a high mortality rate. In the last decades, treatment strategy has shifted from an exclusive surgical approach to a multidisciplinary strategy. Treatment options for patients with resectable gastric cancer as recommended by different w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Slagter, Astrid E., Vollebergh, Marieke A., Jansen, Edwin P. M., van Sandick, Johanna W., Cats, Annemieke, van Grieken, Nicole C. T., Verheij, Marcel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734340/ https://www.ncbi.nlm.nih.gov/pubmed/33330111 http://dx.doi.org/10.3389/fonc.2020.614907

Ejemplares similares

Risk Factors for Metachronous Isolated Peritoneal Metastasis after Preoperative Chemotherapy and Potentially Curative Gastric Cancer Resection: Results from the CRITICS Trial
por: Caspers, Irene A., et al.
Publicado: (2021)

Prognostic value of tumor markers and ctDNA in patients with resectable gastric cancer receiving perioperative treatment: results from the CRITICS trial
por: Slagter, Astrid E., et al.
Publicado: (2021)

Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial
por: Slagter, Astrid E., et al.
Publicado: (2020)

Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
por: Slagter, Astrid E., et al.
Publicado: (2022)

Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
por: Dikken, Johan L, et al.
Publicado: (2011)

Extended lymph node dissection for gastric cancer from a European perspective
por: Dikken, Johan L., et al.
Publicado: (2011)

CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
por: Slagter, Astrid E., et al.
Publicado: (2018)

Health-Related Quality of Life in Locally Advanced Gastric Cancer: A Systematic Review
por: van Amelsfoort, Romy M., et al.
Publicado: (2021)

PD-1 The impact of COVID-19 on diagnosis, stage and treatment of esophageal and gastric cancer
por: Bakx, J., et al.
Publicado: (2022)

Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial
por: Claassen, Y. H. M., et al.
Publicado: (2018)

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies
por: de Klerk, Leonie K., et al.
Publicado: (2021)

COMplot, A Graphical Presentation of Complication Profiles and Adverse Effects for the Curative Treatment of Gastric Cancer: A Systematic Review and Meta-Analysis
por: van den Ende, Tom, et al.
Publicado: (2019)

Failure to Cure in Patients Undergoing Surgery for Gastric Cancer: A Nationwide Cohort Study
por: Voeten, Daan M., et al.
Publicado: (2021)

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
por: Leal, Alessandro, et al.
Publicado: (2020)

The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancer
por: Doeve, Benthe H., et al.
Publicado: (2023)

VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study
por: Smyth, Elizabeth, et al.
Publicado: (2020)

More Controversy than Ever – Challenges and Promises Towards Personalized Treatment of Gastric Cancer
por: Liakakos, Theodore, et al.
Publicado: (2008)

Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials
por: Biesma, Hedde D., et al.
Publicado: (2022)

Postoperative chemoradiotherapy in gastric cancer – a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy
por: Jansen, E P M, et al.
Publicado: (2007)

Positive Phospho-Focal Adhesion Kinase in Gastric Cancer Associates With Poor Prognosis After Curative Resection
por: Peng, Ke, et al.
Publicado: (2022)

Unexpected curative effect of PD-1 inhibitor in gastric cancer with brain metastasis: A case report
por: Wang, Qijun, et al.
Publicado: (2023)

Incidence, Stage, Treatment, and Survival of Noncardia Gastric Cancer
por: van Velzen, Merel J. M., et al.
Publicado: (2023)

Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group
por: Hospers, Geke A., et al.
Publicado: (2007)

Personalized Medicine in Malignant Melanoma: Towards Patient Tailored Treatment
por: Helgadottir, Hildur, et al.
Publicado: (2018)

Detection of asymptomatic recurrence following curative surgery improves survival in patients with gastric cancer: A systematic review and meta-analysis
por: Pang, Hua-Yang, et al.
Publicado: (2022)

Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting
por: Pappalardo, Annalisa, et al.
Publicado: (2021)

Involving the general practitioner during curative cancer treatment: a systematic review of health care interventions
por: Perfors, Ietje A A, et al.
Publicado: (2019)

Histological Differentiated/Undifferentiated Mixed Type Should Not Be Considered as a Non-Curative Factor of Endoscopic Resection for Patients With Early Gastric Cancer
por: Tang, Xiaolong, et al.
Publicado: (2020)

Prognostic and Predictive Biomarkers in Adult and Pediatric Gliomas: Toward Personalized Treatment
por: Haynes, Harry R., et al.
Publicado: (2014)

Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent
por: Parry, K., et al.
Publicado: (2015)

Diffuse Reduction of Spleen Density Is an Independent Predictor of Post-Operative Outcomes After Curative Gastrectomy in Gastric Cancer: A Multi-Center Study
por: Huang, Yun-Shi, et al.
Publicado: (2020)

Clinical outcomes and risk factors of non-curative endoscopic submucosal dissection for early gastric cancer: a retrospective multicenter study in Zhejiang, China
por: Jin, Chao-qiong, et al.
Publicado: (2023)

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma
por: Bielecka, Zofia Felicja, et al.
Publicado: (2014)

Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects
por: Guo, Bin, et al.
Publicado: (2023)

Analysis of the Curative Effect of Neoadjuvant Therapy on Pancreatic Cancer
por: Yang, Liqiong, et al.
Publicado: (2021)

A rare curative case of collecting duct carcinoma
por: Wu, Tielin, et al.
Publicado: (2021)

Concurrent Chemoradiation for Mediastinal Oligometastases From Cervical Cancer: A Potentially Curative Treatment
por: Bonilla, Carlos E, et al.
Publicado: (2020)

Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study
por: van der Kaaij, Rosa T, et al.
Publicado: (2017)

Body Mass Index and Prognosis of Patients With Stage II/III Gastric Cancer After Curative Gastrectomy: Completion of Perioperative Adjuvant Chemotherapy May Be a Confounding Factor
por: Peng, Wei, et al.
Publicado: (2022)

Cardiovascular outcomes after curative prostate cancer treatment: A population-based cohort study
por: Kjellstadli, Camilla, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jg2l892j83ru6s9u1vmldk18bg